BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18653416)

  • 1. APhA2008 House of Delegates: Advancing current practice, preserving pharmacy integrity for the future.
    Marciniak MW; Ried LD; Lipowski EE; Skelton Duke MV
    J Am Pharm Assoc (2003); 2008; 48(4):447-8, 451-4. PubMed ID: 18653416
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing pharmacy practice through policies: development, debate, and consensus in the APhA House of Delegates.
    Boyle CJ; Lipowski EE; Vernon V
    J Am Pharm Assoc (2003); 2011; 51(4):462-5. PubMed ID: 21752766
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minnesota Department of Human Services audit of medication therapy management programs.
    Smith S; Cell P; Anderson L; Larson T
    J Am Pharm Assoc (2003); 2013; 53(3):248-53. PubMed ID: 23699672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building the business model for medication therapy management services.
    Chater RW; Moczygemba LR; Lawson KA; Barner JC; Patterson B; Reed B; Duke MS
    J Am Pharm Assoc (2003); 2008; 48(1):16-22. PubMed ID: 18192126
    [No Abstract]   [Full Text] [Related]  

  • 7. Pay-for-performance model of medication therapy management in pharmacy practice.
    Lenz TL; Monaghan MS
    J Am Pharm Assoc (2003); 2011; 51(3):425-31. PubMed ID: 21555297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APhA2017 House of Delegates: Opportunities for collaboration: The impact of science and research on pharmacy practice.
    Urick B
    J Am Pharm Assoc (2003); 2017; 57(4):429-430. PubMed ID: 28712459
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of medication therapy management programs in Minnesota: 2006-11.
    Larson S; Drake S; Anderson L; Larson T
    J Am Pharm Assoc (2003); 2013; 53(3):254-60. PubMed ID: 23699673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive summary: The Virginia Commonwealth University pharmacy practice transformation conference.
    Matzke GR; Moczygemba LR; Goode JV; Silvester JA
    Ann Pharmacother; 2012 Apr; 46(4):S1-11. PubMed ID: 22499736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacists' role in the Patient-Centered Medical Home (PCMH): a white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA).
    Berdine H; Dougherty T; Ference J; Karpa K; Klootwyk J; Kozminski M; Leon N; Osborne M; Welch AC; Willey VJ; Peterson A; Stanchak LA; Whisler AG
    Ann Pharmacother; 2012 May; 46(5):723-50. PubMed ID: 22535839
    [No Abstract]   [Full Text] [Related]  

  • 13. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare part D: good for patients and an opportunity for pharmacists.
    Benner JS; Kocot SL
    J Manag Care Pharm; 2009; 15(1):66-70. PubMed ID: 19125552
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care reform and the role of the pharmacist.
    Simenson S; Nau DP; Reed B
    J Am Pharm Assoc (2003); 2009; 49(3):356, 360-2. PubMed ID: 19443316
    [No Abstract]   [Full Text] [Related]  

  • 18. Upcoming changes to Medicare Part D affect MTM services.
    Thompson CA
    Am J Health Syst Pharm; 2012 Jun; 69(11):910, 912. PubMed ID: 22610016
    [No Abstract]   [Full Text] [Related]  

  • 19. Professional Policies Approved by the 2019 ASHP House of Delegates.
    Am J Health Syst Pharm; 2019 Sep; 76(18):1442-1445. PubMed ID: 31375820
    [No Abstract]   [Full Text] [Related]  

  • 20. Maryland School of Pharmacy, XLHealth team up on medication management project.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):868, 870. PubMed ID: 20484207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.